Table 1.

Patient baseline and correlation between NCKAP1 expression and clinicopathologic characteristics in hepatocellular carcinoma (HCC)

NCKAP1 expression levels
Clinicopathological variable	No.	Negative	Positive	P value
Age (yr)				0.559
≤50	101	57	44
>50	79	48	31
Gender				0.305
Female	19	9	10
Male	161	96	65
Hepatitis B surface Ag				0.682
Negative	15	8	7
Positive	165	97	68
Serum AFP (ng/mL)				0.325
<400	93	51	42
≥400	87	54	33
Tumor size (cm)				0.235
≤5	70	37	33
>5	110	68	42
Tumor number				0.272
Solitary	134	75	59
Multiple	46	30	16
Microvascular invasion				0.217
No	108	59	49
Yes	72	46	26
PVTT				0.916
No	153	89	64
Yes	27	16	11
Liver cirrhosis				0.494
No	48	30	18
Yes	132	75	57
Differentiation grade				0.467
I + II	112	63	49
III + IV	68	42	26
BCLC stage				0.272
0–A	134	75	59
B–C	46	30	16
TNM stage				0.405
I	87	48	39
II–IV	93	57	36

AFP alpha-fetoprotein, PVTT portal vein tumor thrombus